Legrand Arnaud J, Poletto Mattia, Pankova Daniela, Clementi Elena, Moore John, Castro-Giner Francesc, Ryan Anderson J, O'Neill Eric, Markkanen Enni, Dianov Grigory L
CRUK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Department of Oncology, Old Road Campus Research Building, OX37DQ Oxford, UK.
Institute of Pharmacology and Toxicology, Vetsuisse Faculty, University of Zürich, Zürich 8057, Switzerland.
Oncotarget. 2018 Feb 7;9(17):13666-13681. doi: 10.18632/oncotarget.24446. eCollection 2018 Mar 2.
Cancer-associated fibroblasts (CAFs) are an emerging target for cancer therapy as they promote tumour growth and metastatic potential. However, CAF targeting is complicated by the lack of knowledge-based strategies aiming to selectively eliminate these cells. There is a growing body of evidence suggesting that a pro-inflammatory microenvironment (e.g. ROS and cytokines) promotes CAF formation during tumorigenesis, although the exact mechanisms involved remain unclear. In this study, we reveal that a prolonged pro-inflammatory stimulation causes a deficiency in base excision repair, generating unrepaired DNA strand breaks and thereby triggering an ATF4-dependent reprogramming of normal fibroblasts into CAF-like cells. Based on the phenotype of -generated CAFs, we demonstrate that midostaurin, a clinically relevant compound, selectively eliminates CAF-like cells deficient in base excision repair and prevents their stimulatory role in cancer cell growth and migration.
癌症相关成纤维细胞(CAFs)作为促进肿瘤生长和转移潜能的因素,正成为癌症治疗的一个新兴靶点。然而,由于缺乏旨在选择性消除这些细胞的基于知识的策略,CAF靶向治疗变得复杂。越来越多的证据表明,促炎微环境(如活性氧和细胞因子)在肿瘤发生过程中促进CAF形成,尽管其中的确切机制仍不清楚。在本研究中,我们发现长时间的促炎刺激会导致碱基切除修复缺陷,产生未修复的DNA链断裂,从而触发正常成纤维细胞向CAF样细胞的ATF4依赖性重编程。基于所产生的CAFs的表型,我们证明米哚妥林,一种临床相关化合物,可选择性消除碱基切除修复缺陷的CAF样细胞,并阻止它们在癌细胞生长和迁移中的刺激作用。